APA |
Shahali, A., Akbari, V., Soltani, R., Badri, S., et al. (2022). Drug repositioning approach to target viral and host cells in the terms of COVID-19 treatment: A review of in vivo experiments and clinical studies. Journal of Experimental and Clinical Medicine, 39(4), 1255-1269. |
|
AMA |
Shahali A, Akbari V, Soltani R, Badri S, Alijani Ardeshir R. Drug repositioning approach to target viral and host cells in the terms of COVID-19 treatment: A review of in vivo experiments and clinical studies. J. Exp. Clin. Med. October 2022;39(4):1255-1269. |
|
Chicago |
Shahali, Ali, Vajihe Akbari, Rasool Soltani, Shirinsadat Badri, and Rashid Alijani Ardeshir. “Drug Repositioning Approach to Target viral and Host Cells in the Terms of COVID-19 Treatment: A Review of in Vivo Experiments and Clinical Studies”. Journal of Experimental and Clinical Medicine 39, no. 4 (October 2022): 1255-69. |
|
EndNote |
Shahali A, Akbari V, Soltani R, Badri S, Alijani Ardeshir R (October 1, 2022) Drug repositioning approach to target viral and host cells in the terms of COVID-19 treatment: A review of in vivo experiments and clinical studies. Journal of Experimental and Clinical Medicine 39 4 1255–1269. |
|
IEEE |
A. Shahali, V. Akbari, R. Soltani, S. Badri, and R. Alijani Ardeshir, “Drug repositioning approach to target viral and host cells in the terms of COVID-19 treatment: A review of in vivo experiments and clinical studies”, J. Exp. Clin. Med., vol. 39, no. 4, pp. 1255–1269, 2022. |
|
ISNAD |
Shahali, Ali et al. “Drug Repositioning Approach to Target viral and Host Cells in the Terms of COVID-19 Treatment: A Review of in Vivo Experiments and Clinical Studies”. Journal of Experimental and Clinical Medicine 39/4 (October 2022), 1255-1269. |
|
JAMA |
Shahali A, Akbari V, Soltani R, Badri S, Alijani Ardeshir R. Drug repositioning approach to target viral and host cells in the terms of COVID-19 treatment: A review of in vivo experiments and clinical studies. J. Exp. Clin. Med. 2022;39:1255–1269. |
|
MLA |
Shahali, Ali et al. “Drug Repositioning Approach to Target viral and Host Cells in the Terms of COVID-19 Treatment: A Review of in Vivo Experiments and Clinical Studies”. Journal of Experimental and Clinical Medicine, vol. 39, no. 4, 2022, pp. 1255-69. |
|
Vancouver |
Shahali A, Akbari V, Soltani R, Badri S, Alijani Ardeshir R. Drug repositioning approach to target viral and host cells in the terms of COVID-19 treatment: A review of in vivo experiments and clinical studies. J. Exp. Clin. Med. 2022;39(4):1255-69. |
|